|
October 27, 2009
Ruder Finn has won the Pfizer oncology communications project in a competitive pitch against local and international agencies. The nationwide project is targeted at doctors and patients and will introduce the first large scale research study of breast cancer in China. Ruder Finn services will include media relations, corporate branding in the therapeutic area, and organizing city tours of key opinion leaders.
Pfizer is the world's largest research-based biomedical and pharmaceutical company, with a leading portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas. In January 2009, Pfizer acquired Wyeth Pharmaceuticals.
“This is a spectacular win for Ruder Finn especially in such a significant area of treatment. Our expertise and long term experience in this market, as well as our strong regional media network can certainly help Pfizer make a major contribution in helping the Chinese community “ says Jean Michel Dumont, Chairman, Ruder Finn Asia. “It’s been a great year for Ruder Finn in the Healthcare Communications sector!”
This will be Ruder Finn’s first cooperation with Pfizer in China. This win adds to Ruder Finn’s already impressive client roster in Asia Pacific, which includes Novartis, MSD, Elsevier, Astellas Pharma, AstraZeneca, Mead Johnson, Merck Sharp & Dohme (MSD), Roche, Wyeth, Sandoz and Schering Plough Pharmaceuticals. Ruder Finn has more than 10 years experience and expertise in healthcare communications in China and has established a strong reputation in the pharmaceutical industry.
******
Ruder Finn, Inc.is one of the largest independent integrated communication firms in the world, with offices in Chicago, Los Angeles, New York, San Francisco, Washington, Beijing, Hong Kong, Shanghai, Guangzhou, Singapore, London, Paris and Jerusalem. Through offices and affiliates worldwide, the agency serves the global and local communication needs of over 250 corporations, governments and nonprofit organizations.
Ruder Finn’s business is structured under four strategic platforms. In Asia, Health & Wellness covers Li Ning, Roche, MSD and others. Life & Style covers luxury brands from the Richemont Group such as Cartier, Dunhill, Vacheron Constantin and LVMH Group, Hennessy X.O and Veuve Clicquot, as well as Hermes, Bang & Olufsen and Audi. Global Connectivity covers DHL, Emirates, IPC and others. Corporate & Public Trust includes Michelin, Boeing, Volkswagen, Visa and others. For more information on Ruder Finn, please visit www.ruderfinnasia.com
|
